BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $689,737 | -30.6% | 18,276 | -16.2% | 0.06% | -27.6% |
| Q2 2023 | $994,165 | +3.1% | 21,821 | -8.2% | 0.08% | -2.6% |
| Q1 2023 | $963,916 | -33.0% | 23,765 | -15.8% | 0.08% | -35.0% |
| Q4 2022 | $1,438,892 | -5.5% | 28,230 | -0.1% | 0.12% | -12.4% |
| Q3 2022 | $1,523,000 | -17.4% | 28,272 | -1.5% | 0.14% | -17.5% |
| Q2 2022 | $1,844,000 | -12.3% | 28,714 | +5.9% | 0.17% | +4.4% |
| Q1 2022 | $2,103,000 | -10.3% | 27,124 | -0.7% | 0.16% | -5.4% |
| Q4 2021 | $2,345,000 | +5.8% | 27,319 | -0.9% | 0.17% | -2.9% |
| Q3 2021 | $2,216,000 | -1.3% | 27,555 | -1.2% | 0.17% | +0.6% |
| Q2 2021 | $2,245,000 | -4.8% | 27,891 | -0.2% | 0.17% | -10.9% |
| Q1 2021 | $2,357,000 | +4.0% | 27,947 | -1.0% | 0.19% | -1.0% |
| Q4 2020 | $2,266,000 | -0.8% | 28,236 | -0.6% | 0.20% | -12.6% |
| Q3 2020 | $2,284,000 | -13.9% | 28,398 | -7.9% | 0.22% | -21.2% |
| Q2 2020 | $2,654,000 | +14.3% | 30,823 | +7.8% | 0.28% | -5.4% |
| Q1 2020 | $2,322,000 | -10.0% | 28,599 | -7.3% | 0.30% | +15.4% |
| Q4 2019 | $2,579,000 | -6.6% | 30,846 | -2.3% | 0.26% | -13.4% |
| Q3 2019 | $2,762,000 | +5.7% | 31,573 | -1.1% | 0.30% | +4.9% |
| Q2 2019 | $2,614,000 | -4.8% | 31,919 | -5.5% | 0.28% | -5.3% |
| Q1 2019 | $2,747,000 | +24.1% | 33,782 | +0.4% | 0.30% | +10.7% |
| Q4 2018 | $2,214,000 | -16.4% | 33,636 | -2.1% | 0.27% | -2.5% |
| Q3 2018 | $2,649,000 | +2.1% | 34,361 | -2.2% | 0.28% | -5.1% |
| Q2 2018 | $2,595,000 | +11.7% | 35,140 | -1.6% | 0.29% | +8.5% |
| Q1 2018 | $2,324,000 | -2.9% | 35,725 | -3.5% | 0.27% | +1.9% |
| Q4 2017 | $2,393,000 | +0.2% | 37,015 | -2.8% | 0.27% | -5.7% |
| Q3 2017 | $2,389,000 | -0.1% | 38,068 | -3.6% | 0.28% | -3.4% |
| Q2 2017 | $2,391,000 | +13.0% | 39,497 | -3.1% | 0.29% | +9.0% |
| Q1 2017 | $2,115,000 | +15.3% | 40,774 | -1.5% | 0.27% | +9.8% |
| Q4 2016 | $1,835,000 | -5.6% | 41,384 | -3.7% | 0.24% | -7.6% |
| Q2 2016 | $1,943,000 | +3.5% | 42,973 | -6.0% | 0.26% | +2.7% |
| Q1 2016 | $1,878,000 | +4.3% | 45,708 | -3.2% | 0.26% | +1.6% |
| Q4 2015 | $1,801,000 | +100.3% | 47,203 | +72.5% | 0.25% | +93.1% |
| Q3 2015 | $899,000 | -52.9% | 27,364 | +0.3% | 0.13% | -48.2% |
| Q2 2015 | $1,908,000 | -38.5% | 27,291 | -35.6% | 0.25% | -38.4% |
| Q4 2014 | $3,104,000 | +10.8% | 42,361 | +8.5% | 0.41% | +5.9% |
| Q3 2014 | $2,801,000 | +1.0% | 39,026 | +1.8% | 0.39% | +2.1% |
| Q2 2014 | $2,772,000 | +1.6% | 38,346 | +3.4% | 0.38% | -2.1% |
| Q1 2014 | $2,729,000 | +9.7% | 37,086 | +3.7% | 0.39% | +4.0% |
| Q4 2013 | $2,488,000 | +8.3% | 35,761 | +2.2% | 0.37% | -0.8% |
| Q3 2013 | $2,298,000 | -3.8% | 34,986 | +1.4% | 0.38% | -8.3% |
| Q2 2013 | $2,389,000 | – | 34,497 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |